03 Profile
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Dr. Stanley Crooke
Founder of Ionis Pharmaceuticals, CNBC Advisory Board member
press citation on 1 topic since 30 Jan 2026 · last quoted 30 Jan 2026
02 Quoted on · 1 of 29 topics
Dr. Stanley Crooke: key facts
- Kind of voice
- Academic
- Role
- Founder of Ionis Pharmaceuticals, CNBC Advisory Board member
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 30 Jan 2026
04 The signal · where Dr. Stanley Crooke sits on rare diseases
Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
- 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
- 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
- 25=Dorte X. GramSector leaderfounder and CSO of Pila Pharma1
- 25=Hans QuidingAcademicPila Pharma's scientific expert in pain management1
- 25=Dr. Stanley CrookeAcademicFounder of Ionis Pharmaceuticals, CNBC Advisory Board member1
- 25=Mary NicholsonSector leaderhead of advocacy at Debra, the national charity for EB1
- 25=Emma MacleodAcademicPrincipal Investigator for Portsmouth Hospitals University NHS Trust1
Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →
05 On the record · press
What Dr. Stanley Crooke has said
- cnbc.com1
Where Dr. Stanley Crooke has been quoted
Verbatim
“The FDA defines rare disease as a patient population of 200,000. But we now know that there are many, many pathogenic mutations that produce disease in far fewer patients ... And our focus is on these patients, because they have no hope.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.